| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | Aprea Therapeutics, Inc. | Director | Buy | 86.3 | +21,459 | 9.12% | ✗ | $25K |
| Oct 18, 2024 | Oct 25, 2024 | Aprea Therapeutics, Inc. | Director | Sell | 26.3 | -6,462 | -2.68% | ✗ | $29.6K |
| Oct 16, 2024 | Oct 17, 2024 | Aprea Therapeutics, Inc. | Director | Buy | 95.0 | +30,000 | 14.24% | ✗ | $131.7K |
| Oct 14, 2024 | Oct 16, 2024 | Aprea Therapeutics, Inc. | Director | Buy | 55.0 | +190 | 0.09% | ✗ | $490.2 |